Clinical trials to begin on two new COVID-19 vaccines developed by Melbourne researchers

Clinical trials are set to begin on two new COVID-19 vaccines being developed in Melbourne that researchers say may improve immunity to the Omicron variant.

The two vaccines were created by researchers at the Doherty Institute and Monash Institute of Pharmaceutical Sciences (MIPS).

The trials will assess the effectiveness of the vaccines as a fourth dose, and will involve people who have already had three doses of a vaccine.

Researchers said the jabs were distinct from existing vaccines as they targeted the tip of the virus spike protein, known as the receptor binding domain (RBD).

Read More: https://www.abc.net.au/news/2022-03-25/trials-to-begin-on-new-australian-covid-vaccines/100938258